NCT07368478 2026-01-26A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid MalignanciesBiocity Biopharmaceutics Co., Ltd.Phase 1 Recruiting180 enrolled